Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Law

Showing results (231-240 of 263) with videos related to

Pageof 27
Sort By:
Trials|February 13, 2016
Effectiveness of blood flow restricted exercise compared with standard exercise in patients with recurrent low back pain: study protocol for a randomized controlled trialShinichi Amano, Arimi Fitri Mat Ludin, Rachel Clift, et al.
Research Square|February 24, 2023
Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neuronsRachel J Boyd, Sarah A McClymont, Nelson B Barrientos, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 28, 2025
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHDJongbok Lee, Hyeonjeong Kang, Branson Chen, et al.
Transplantation and Cellular Therapy|June 13, 2025
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant with Graft Failure and Relapse Risk in Hematological MalignanciesAhmed Alnughmush, Mats Remberger, Vathany Kulasingam, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 6, 2021
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant PatientsEshrak Al-Shaibani, Rhida Bautista, Jeffrey H Lipton, et al.
Medicine and Science in Sports and Exercise|March 27, 2019
Blood Flow-restricted Exercise Does Not Induce a Cross-Transfer of Effect: A Randomized Controlled TrialKwasi Ampomah, Shinichi Amano, Nathan P Wages, et al.
The European Respiratory Journal|March 17, 2018
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplantTakashi Hirama, Sarah K Brode, Jenifer Beswick, et al.
European Journal of Haematology|July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remissionTommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
British Journal of Haematology|February 26, 2026
Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemiaNihar Desai, Mohammed Althobaiti, Carol Chen, et al.
Transplantation and Cellular Therapy|May 16, 2026
Prior Malignancy History and Risk of Second Malignancies After Allogeneic Hematopoietic Cell TransplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Pageof 27

Showing results (231-240 of 263) with videos related to

Sort By:
Pageof 27
Trials|February 13, 2016
Effectiveness of blood flow restricted exercise compared with standard exercise in patients with recurrent low back pain: study protocol for a randomized controlled trialShinichi Amano, Arimi Fitri Mat Ludin, Rachel Clift, et al.
Research Square|February 24, 2023
Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neuronsRachel J Boyd, Sarah A McClymont, Nelson B Barrientos, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 28, 2025
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHDJongbok Lee, Hyeonjeong Kang, Branson Chen, et al.
Transplantation and Cellular Therapy|June 13, 2025
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant with Graft Failure and Relapse Risk in Hematological MalignanciesAhmed Alnughmush, Mats Remberger, Vathany Kulasingam, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 6, 2021
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant PatientsEshrak Al-Shaibani, Rhida Bautista, Jeffrey H Lipton, et al.
Medicine and Science in Sports and Exercise|March 27, 2019
Blood Flow-restricted Exercise Does Not Induce a Cross-Transfer of Effect: A Randomized Controlled TrialKwasi Ampomah, Shinichi Amano, Nathan P Wages, et al.
The European Respiratory Journal|March 17, 2018
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplantTakashi Hirama, Sarah K Brode, Jenifer Beswick, et al.
European Journal of Haematology|July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remissionTommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
British Journal of Haematology|February 26, 2026
Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemiaNihar Desai, Mohammed Althobaiti, Carol Chen, et al.
Transplantation and Cellular Therapy|May 16, 2026
Prior Malignancy History and Risk of Second Malignancies After Allogeneic Hematopoietic Cell TransplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Pageof 27